experimental group:streptococcus salivarius K12

2 trials

Sponsors

West China Hospital, Sichuan University, Peking University Hospital of Stomatology

Conditions

Head and neck squamous cell carcinoma (include nasopharyngeal carcinoma)Oral Candidiasis

Phase 2

A single-center, open-label, randomized controlled clinical trial of Streptococcus salivarius K12 to reduce severe oral mucositis due to intensity modulated radiotherapy for head and neck squamous cell carcinoma (include nasopharyngeal carcinoma)

RecruitingChiCTR2100054689

West China Hospital, Sichuan UniversityHead and neck squamous cell carcinoma (include nasopharyngeal carcinoma)

Start: 2021-12-10Updated: 2023-01-16

Phase 4

Efficacy of Streptococcus livarius K12 in the Treatment of Oral Candidiasis - A Randomized Controlled Trial

Active, not recruitingChiCTR-TRC-14005090

Peking University Hospital of StomatologyOral Candidiasis

Start: 2014-08-15Updated: 2018-10-10